News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Jazz Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioMidwest
3 Bargain Pharma Stocks to Watch
June 7, 2016
·
3 min read
Biotech Beach
3 Bargain Biotech Stocks to Buy Right Now
June 3, 2016
·
2 min read
Deals
Jazz Pharma Pays $1.5 Billion for Celator Pharma to Gain a Promising Leukemia Drug
May 31, 2016
·
2 min read
Policy
Gilead, Biogen, Jazz Pharma Subpoenaed as Feds Investigate Drugmaker-Charity Connections
May 27, 2016
·
4 min read
Policy
Three Drugmakers Facing FDA Decisions This Quarter
March 9, 2016
·
3 min read
Biotech Bay
Regeneron Stock Rocks, but Vertex, Medivation & Jazz Pharma Roll
February 3, 2016
·
4 min read
Business
Jazz Pharmaceuticals Signs Lease for Big Space in Palo Alto
January 13, 2015
·
1 min read
The Day In Review: Acquisitions Help Biotech
October 19, 2005
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Jazz Pharmaceuticals Presents Positive Data from Phase 2/3 Trial of Rylaze® (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma at the ASCO 2022 Annual Meeting
June 7, 2022
·
11 min read
Biotech Bay
Jazz Pharmaceuticals to Participate in the Jefferies Healthcare Conference - June 01, 2022
June 1, 2022
·
1 min read
Jazz Pharmaceuticals to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine
June 1, 2022
·
11 min read
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advancements Across Oncology Portfolio at 2022 ASCO and EHA Meetings
May 12, 2022
·
20 min read
Business
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics
May 9, 2022
·
6 min read
Deals
Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
May 9, 2022
·
14 min read
Business
Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance
May 4, 2022
·
40 min read
Biotech Bay
Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist
May 4, 2022
·
8 min read
Biotech Bay
Jazz Pharmaceuticals to Participate in the BofA Securities 2022 Global Healthcare Conference
May 3, 2022
·
1 min read
Business
Jazz Pharmaceuticals to Report 2022 First Quarter Financial Results on May 4, 2022
April 20, 2022
·
1 min read
